16th Annual Indy Hematology Review

16th Annual Indy Hematology Review

A full day of presentations by today's leaders in Hematology and Hematologic Malignancies.

REFUND POLICY: Request a registration cancellation refund on or before February 22, 2019, to receive a Full Refund. After February 22, there is NO REFUND.

SCHOLARSHIPS: A limited number of scholarships are available for students, residents, fellows, and nurses on a first-come, first-served basis. To register for a scholarship, please contact Indyhr@conventionmanagers.com for availability.

HOTEL RESERVATIONS: Make your reservation online at https://book.passkey.com/go/IndyHematology or call the JW Marriott Indianapolis at 317-860-5800 or toll free at 1-888-236-2427. Mention “Indy Hematology Review” to receive the discounted rate of $192 plus tax (currently 17%). Access to the block of discounted rooms will close on Friday, February 15, 2019.

PARKING: Parking is available at the JW Marriott Indianapolis. 24-hour parking rates are currently: $44 on-site parking; $49 valet. Self-parking is also available at the Government Center Washington St. Parking Facility, 401 West Washington Street: First Hour is $15; Daily Maximum is $25.

CONTINUING EDUCATION CREDITS:

LEARNING OBJECTIVES
At the completion of this activity, participants should be able to:

1. Discuss new emerging hematology therapies in general and for chronic Myeloid Leukemia, acute Promylelocytic and Myeloid Leukemia, and Myeloproliferative neoplasms.
2. Evaluate molecular diagnosis, targeted therapies, and resistance mechanisms of Waldenström’s Macroglobulinemia to assist in disease recognition.
3. Discuss the advancement of immune check point inhibitors within hematologic malignancies and updated treatment paradigms presented at the American Society of Hematology meeting in San Diego, CA in December 2018.
4. Recommend new regimens for Hematopoietic Stem Cell transplantation and identification of transplant candidates.
5. Review the advancement in benign hematology research.
6. Review new treatment regimens in follicular lymphoma.

CME Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and Indy Hematology Education, Inc. Purdue University is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement:

Purdue University College of Pharmacy designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement:

All faculty, staff, and reviewers involved in the planning, review, or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. All additional planning committee members, staff, and reviewers of Indy Hematology Education, Inc. and Purdue University College of Pharmacy have no relationships to disclose.

NOTE: While it offers CME credits, this activity is not intended to provide extensive training or certification in the field.

Nurses Accreditation Statement:

Purdue University Continuing Nursing Education is accredited as a provider of continuing nursing education with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.

This program is approved for 8.0 contact hours.

Pharmacists Accreditation Statement:

Purdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge based, continuing education activity of Purdue University, an equal access/equal opportunity institution.

Universal Activity Number (UAN): 0018-9999-19-001-L01-P

This program is approved for 8.0 contact hours (0.8 CEU’s).

QUESTIONS? Please contact 317-841-7171 or Indyhr@conventioinmanagers.com

WEBSITE: http://www.indyhematologyreview.com/